Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001415889-22-003937
Filing Date
2022-04-07
Accepted
2022-04-07 16:13:24
Documents
2
Period of Report
2022-04-06

Document Format Files

Seq Description Document Type Size
1 form3-04072022_010416.html 3  
1 form3-04072022_010416.xml 3 1751
2 ex24-04072022_010417.htm EX-24 8397
  Complete submission text file 0001415889-22-003937.txt   11480
Mailing Address
Business Address
DIXON WENDY L (Reporting) CIK: 0001202283 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39200 | Film No.: 22814000

Mailing Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 10TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Issuer) CIK: 0001701541 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)